Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	52
Overall Study	STARTED	Leu Sil 1.0mg	51
Overall Study	STARTED	Leu Sil 4.0mg	53
Overall Study	STARTED	Leu Met Sil 1.0mg	50
Overall Study	STARTED	Leu Met Sil 4.0mg	52
Overall Study	COMPLETED	Placebo	42
Overall Study	COMPLETED	Leu Sil 1.0mg	40
Overall Study	COMPLETED	Leu Sil 4.0mg	42
Overall Study	COMPLETED	Leu Met Sil 1.0mg	37
Overall Study	COMPLETED	Leu Met Sil 4.0mg	41
Overall Study	NOT COMPLETED	Placebo	10
Overall Study	NOT COMPLETED	Leu Sil 1.0mg	11
Overall Study	NOT COMPLETED	Leu Sil 4.0mg	11
Overall Study	NOT COMPLETED	Leu Met Sil 1.0mg	13
Overall Study	NOT COMPLETED	Leu Met Sil 4.0mg	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03364335/flow